Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Systematic Review of Phase III Trials of Daratumumab Based Regimens in Relapsed Refractory Multiple Myeloma

Karun Neupane, MBBS,MD, Zahoor Ahmed, MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Arafat Ali Farooqui, MD, Muhammad Salman Faisal, MD MBBS, Syed Maaz Abdullah, MBBS, Richi Kashyap, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-134305

Published: 2020

Journal Articles

A Systematic Review of Phase III Clinical Trials of Daratumumab Addition to Standard Care Regimen for Newly Diagnosed Multiple Myeloma

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Arafat Ali Farooqui, MD, Muhammad Salman Faisal, MD MBBS, Shaha Nabeel, MD, Abdur Rehman Jamil, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-134895

Published: 2020

Journal Articles

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Eligible Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Abdul Rafae, MD, Moazzam Shahzad, MD, Muhammad Saad Farooqi, MDMBBS, Sundas Ali, MBBS, MD, Saad Javed, MD, Richi Kashyap, MD, Shaha Nabeel, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 36.

https://doi.org/10.1182/blood-2020-141761

Published: 2020

Journal Articles

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Muhammad Salman Faisal, MD MBBS, Sana Irfan Khan, MD, Abdul Rafae, MD, Arshia Akbar, MDMBBS, Ahsan Wahab, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-137141

Published: 2020

Journal Articles

A Systematic Review of Daratumumab Based Four Drug Regimen for Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials

Karun Neupane, MBBS,MD, Zahoor Ahmed, MD, Amna Khan, MBBS, MD, Rabia Ashraf, MBBS, MD, Moazzam Shahzad, MD, Shaha Nabeel, MD, Arshia Akbar, MDMBBS, Saad Javed, MD, Syed Maaz Abdullah, MBBS, Unaiza Faizan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-138466

Published: 2020

NARROW

Systematic Review of Phase III Trials of Daratumumab Based Regimens in Relapsed Refractory Multiple Myeloma

A Systematic Review of Phase III Clinical Trials of Daratumumab Addition to Standard Care Regimen for Newly Diagnosed Multiple Myeloma

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Eligible Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

A Systematic Review of Daratumumab Based Four Drug Regimen for Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials

Email alerts

ASH Publications

American Society of Hematology

Systematic Review of Phase III Trials of Daratumumab Based Regimens in Relapsed Refractory Multiple Myeloma

A Systematic Review of Phase III Clinical Trials of Daratumumab Addition to Standard Care Regimen for Newly Diagnosed Multiple Myeloma

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Eligible Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

A Systematic Review of Daratumumab Based Four Drug Regimen for Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only